The latest research in Dermatology is available online now: take a look at JDD‘s March 2020 content highlights:
- Azelaic acid 15% foam may be an efficacious therapy for rosacea while also offering a better side effect profile in Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam
- Nail Surgery Myths and Truths dispels common myths encountered by dermatologists when performing nail surgery.
-
The Effects of Primary Defect Characteristics on Reconstruction Type and Adjunctive Intervention in Mohs Micrographic Surgery: A Retrospective Review may help counsel patients of the potential need for adjunctive cosmetic procedures following surgical repair of facial Mohs defects
-
Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis: Data from the British Association of Dermatologists Biologic Interventions Register (BADBIR) considers all aspects of the disease that have the greatest impact on the patient’s everyday life
-
Efficacy and Safety of Systemic Treatments for Skin and Joint MField Therapy in Solid Organ Transplant Recipients: Are We Initiating Early Enough? illuminates the lack of field therapy use in organ transplant recipients with low NMSK burden compared to those with a high burden.
View all March 2020 JDD content, including editor’s picks, supplements, CME activities, case reports, and more!
View Now
You May Also Like
Beyond Claims: Objective Insights Into Cleanser Mildness for Sensitive Skin
Beyond Claims: Objective Insights Into Cleanser Mildness for Sensitive Skin
What if “gentle” isn’t as gentle as we think? This webinar brings together objective cleanser mildness data and real‑world sensitive skin research from the Global Sensitive Skincare Faculty to challenge…
La Roche-Posay: Intercepting Melanin Precursors for Next-Generation Dark Spot Correction
La Roche-Posay: Intercepting Melanin Precursors for Next-Generation Dark Spot Correction
Join Janiene Luke, MD, to discover how MELAB3’s breakthrough active, Melasyl (2 MNG), intercepts melanin precursors before they form dark spots, setting a new standard for safety and efficacy across…
From Barrier to Follicle: New Frontiers in Skin and Scalp Science from CeraVe and Vichy Dercos
From Barrier to Follicle: New Frontiers in Skin and Scalp Science from CeraVe and Vichy Dercos
Join Victoria Barbosa, MD to learn about new OTC solutions for dandruff management and overall scalp and hair health for all hair and curl types. Faculty Victoria Barbosa, MD Get…






